New research in The FASEB Journal suggests that these lab-grown cells express a broad array of natural and potent protective agents providing preservation and protection against injury, toxins and diseases
A group of really brainy scientists have moved closer to growing “therapeutic” brain cells in the laboratory that can be re-integrated back into patients’ brains to treat a wide range of neurological conditions. According to new research published online in The FASEB Journal, brain cells from a small biopsy can be used to grow large numbers of new personalized cells that are not only “healthy,” but also possess powerful attributes to preserve and protect the brain from future injury, toxins and diseases. Scientists are hopeful that ultimately these cells could be transformed in the laboratory to yield specific cell types needed for a particular treatment, or to cross the “blood-brain barrier” by expressing specific therapeutic agents that are released directly into the brain.
“This work is an example of how integrating basic science and clinical care may reveal privileged opportunities for biomedical research,” said Matthew O. Hebb, M.D., Ph.D., FRCSC, a researcher involved in the work from the Departments of Clinical Neurological Sciences (Neurosurgery), Oncology and Otolaryngology at the University of Western Ontario in Ontario, Canada. “It is our hope that the results of this study provide a footing for further advancement of personalized, cell-based treatments for currently incurable and devastating neurological disorders.”
Scientists enrolled patients with Parkinson’s disease who were scheduled to have deep brain stimulation (DBS) surgery, a commonly used procedure that involves placing electrodes into the brain. Before the electrodes were implanted, small biopsies were removed near the surface of the brain and multiplied in culture to generate millions of patient-specific cells that were then subjected to genetic analysis. These cells were complex in their make-up, but exhibited regeneration and characteristics of a fundamental class of brain cells, called glia. They expressed a broad array of natural and potent protective agents, called neurotrophic factors.
“From an extremely small amount of brain tissue, we will one day be able to do very big things,” said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. “For centuries, treating the brain effectively and safely has been elusive. This advance opens the doors to not only new therapies for a myriad of brain diseases, but new ways of delivering therapies as well.”
The Latest on: Brain disease therapies
- Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019on December 2, 2019 at 4:33 pm
The BETonMACE study and effects of apabetalone 100 mg b.i.d. two years treatment on cognition in diabetes patients with established cardiovascular disease: Dr. Jeffrey Cummings, Cleveland Clinic Lou ...
- New test for Lyme disease could spot the tick-borne infection in just 15 minuteson December 2, 2019 at 4:20 pm
Former England rugby union star Matt Dawson, 47, needed specialist heart treatment ... to irreversible brain damage. Victims lose control over their bodies and become dependent on 24-hour care.
- 11-Year Old Disease Fighter Joins Global GivingTuesday With a Goal to Cure Rare Brain Diseaseon December 2, 2019 at 4:07 pm
In addition to the Facebook campaign, Ellie’s family, friends and supporters have raised over $1 million for pediatric neurological disease research ... for gene therapy - a process that helps ...
- Parkinson's Treatment Has Unexpected Side Effecton December 2, 2019 at 2:28 pm
MONDAY, Dec. 2, 2019 (HealthDay News) -- Some Parkinson's patients who have a deep brain stimulation device implanted to control their symptoms have reported an odd side effect -- they lost the ...
- A new offensive against Alzheimer's diseaseon December 2, 2019 at 1:18 pm
"We hope that this research will lead to the identification of new prevention and treatment targets for this widespread and debilitating ... Amyloid plaque accumulation in the brain has been ...
- New drug shows promising results in the treatment of Alzheimer’son December 2, 2019 at 12:11 pm
“The drug is aducanumab,” he said. “It was targeted for people who have very mild symptoms we call mild cognitive impairment." Alzheimer's is a degenerative disease that affects circuits of the brain ...
- Stimulus package: brain stimulation holds huge promise, but is critically under-regulatedon December 2, 2019 at 10:13 am
The treatment aims to help Yan conquer his methamphetamine addiction ... Neurological disorders are a leading — and increasing — cause of global disease, contributing more than 10% of disease burden.
- The influence of environment and origin on brain resident macrophages and implications for therapyon December 2, 2019 at 10:06 am
Recent studies identify the contributions of both brain environment and developmental history to the transcriptomic ... with particular focus on existing and future therapies using bone-marrow- or ...
- Brain receptor that regulates body temperature may also be the key to rapid weight losson December 2, 2019 at 9:00 am
The brain mechanism that enables us to ... The findings will be further explored as a potential treatment approach for obesity, which the World Health Organization has called a global epidemic.
- How individual cell types in the brain contribute to Alzheimer's diseaseon December 2, 2019 at 6:44 am
Despite this and the myriad investments into research on the disease, there is currently no effective treatment and an effective drug is yet to be discovered ... have now published a comprehensive and ...
via Google News and Bing News